MARYLIN JEFFREY: Open Payments
NPI 1972247856 · AUGUSTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,717 in 97 payments from 23 companies in 2025. Trend: 2023 $2,448 · 2024 $4,813 · 2025 $2,717
Food & beverage: $2,717
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 27 | $812 |
| JAZZ PHARMACEUTICALS INC. | 6 | $309 |
| Neurelis, Inc. | 11 | $269 |
| CATALYST PHARMACEUTICALS, INC. | 12 | $242 |
| AstraZeneca Pharmaceuticals LP | 2 | $126 |
| Tanabe Pharma America, Inc. | 5 | $117 |
| ARGENX US, INC. | 4 | $105 |
| Lilly USA, LLC | 1 | $98 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $80 |
| BIOCODEX, INC. | 2 | $76 |
Products named: EPIDIOLEX, VALTOCO, FYCOMPA, Fintepla, Briviact, Rystiggo, Radicava, LOKELMA.
Industry payments across GA — which companies pay providers there.
